Guizhou Xinbang Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 3,098.247 million compared to CNY 2,702.504 million a year ago. Operating income was CNY 179.950 million compared to CNY 48.234 million a year ago. Net income was CNY 152.630 million compared to CNY 35.748 million a year ago. Basic earnings per share from continuing operations was CNY 0.0964 compared to CNY 0.0225 a year ago.